Atwell, a PhD candidate
in Global Disease Epidemiology and Control at the Johns Hopkins Bloomberg School of Public Health, says it is difficult to quantify the contributions of different factors to the resurgence of pertussis and that it is a multifaceted issue.
Not exact matches
Important factors that could cause actual results to differ materially from those reflected
in such forward - looking statements and that should be considered
in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases
in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the effect of
global economic conditions on the business aircraft market and expanding conflicts or political unrest
in the Middle East or Asia; 7) customer cancellations or deferrals as a result of
global economic uncertainty or otherwise; 8) the effect of economic conditions
in the industries and markets
in which we operate
in the U.S. and globally and any changes therein, including fluctuations
in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain
in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of
diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both
in the U.S. and abroad; 20) the effect of changes
in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction
in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco
in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations
in foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.
«Expanding our collaboration with Banner Alzheimer's Institute stands testament to our belief that preventing amyloid buildup is one of the most promising approaches to treating Alzheimer's
disease,» said Novartis» chief medical officer,
global head of drug development, and soon - to - be CEO Dr. Vas Narasimhan
in a statement.
High percentages of those polled also believe A.I. can make significant advances
in eradicating cancer and
diseases, developing clean energy, improving education, and boosting
global health and well - being.
Crops of cocoa have been suffering due to dry weather
in West Africa, where most cocoa is produced, and a fungal
disease that has wiped out around a third of
global coca production.
Center for
Disease Control Director Tom Frieden participates
in a discussion about «Zika, the Olympics, and
Global Health Security: A Marathon Against a Microbe» at New America July 13, 2016
in Washington, DC.
This means that
in the
global fight against malaria, we need to do everything we can to slow the rise of drug - resistant forms of the
disease.
But with the
disease still killing a child
in Africa every few minutes, those eager to finish the job are worried that the presidency of the United States — a crucial funding source for international malaria control efforts — is now passing to a man whose commitment to
global health projects is uncertain.
It is almost a decade since Gates first dared to revive what
in global health circles is known as the «e-word»
in relation to this ancient
disease.
To accomplish this, the new WHO report estimates that
global funding for combating the
disease will have to increase from the $ 2.7 billion that's spent today to $ 8.7 billion
in 2030.
JOHANNESBURG, March 19 - Tiger Brands has closed its factory
in Pretoria after listeria was detected at the plant as South Africa faces the worst
global outbreak of the
disease that has killed 180 people since January 2017.
The
global health community and a coalition of public - private initiatives has successfully begun taming the scourge, with a 21 % decrease
in its
global incidence and 29 % drop
in mortality rate between 2010 and 2015; still, there were 212 million malaria cases worldwide and nearly 430,000 deaths from the
disease in 2015, according to the latest World Health Organization (WHO) figures.
International philanthropy and the western world's desire to eradicate poverty and
disease can't ever truly rid themselves of their imperialist roots; as many critics have pointed out, the white savior industrial complex has never been more pervasive
in global culture.
JCAR015 is among CAR T - cell candidates covered by Juno's 10 - year, approximately $ 1 billion
global collaboration launched
in 2015 to develop and commercialize cancer and autoimmune
diseases immunotherapies.
As the event opened, the panellists were presented with five
global risk scenarios: uncontrolled city growth, lack of fresh water, extreme weather, continued fossil fuel lock -
in and rising cases of non-communicable
diseases (NCDs).
Antares Pharma (ATRS)- The company possesses a strong pipeline of drug / device combination product candidates which provide better treatment options
in a variety of
disease settings - Xyosted could potentially be approved by September and should see significant adoption due to several advantages over current treatments (keep
in mind
global male hypogonadism market to exceed $ 3 billion within 10 years).
The
global race for AI chip dominance heats up: We're seeing a Cambrian explosion of applications for artificial intelligence, from recognizing faces
in videos for security purposes to detecting
diseases in medical images at scale.
This is hypothesized to happen for many different reasons, including a decline
in the competitiveness of other economic sectors (caused by appreciation of the real exchange rate as resource revenues enter an economy, a phenomenon known as Dutch
disease), volatility of revenues from the natural resource sector due to exposure to
global commodity market swings, government mismanagement of resources, or weak, ineffectual, unstable or corrupt institutions (possibly due to the easily diverted actual or anticipated revenue stream from extractive activities).
Global Health Now recently captured photographs of a community
in Kahemba under the ill effects of this
disease.
Well, the last time Americans had a president who was psychologically «programmed» to ignore facts that didn't agree with his beliefs, the USA ended up wasting $ 1T
in an illegal war to «liberate» 100's of billions of barrels of Iraqi oil (as many as 1.2 M people died
in the process due to violence,
disease & starvation resulting from the conflict), nearly $ 5T was added to the U.S. federal debt, a man with experience as the Judges and Stewards Commissioner for the International Arabian Horse Association was put
in charge of the Federal Emergency Management Agency (FEMA), the U.S. subprime credit «bubble» expanded hugely & then imploded, wiping out some $ 14T
in global wealth & destroying millions of jobs, etc..
Which God promises, to restore the earth
in to a
global paradise, and eliminating, death,
diseases, violence, and to give everlasting life to humans?
I guess that
in a world where 39,000 children die each day from preventable
disease, where around 90,000 civilians have been killed
in Iraq, where the current
global food crisis causes a child to die every seven seconds, where 47 million Americans can not afford basic healthcare, and where women and children continue to be murdered
in Darfur — nothing says «God is pro-life» better than a bunch of wet democrats.
So why is the world's oldest
disease still feared and reviled
in the
global Church today?
If you don't like comparisons with morbidity by
disease, how about the ~ 16,000 homicides
in the US — more than * all *
global terrorism.
According to United Nations Foundation executive director Elizabeth Gore, this partnership is a natural step
in the fight against
global poverty and
disease.
So the alarmist community has reacted predictably by issuing ever more apocalyptic statements, like the federal report»
Global Change Impacts
in the United States» issued last week which predicts more frequent heat waves, rising water temperatures, more wildfires, rising
disease levels, and rising sea levels — headlined,
in a paper I read, as «Getting Warmer.»
So why is the world's oldest
disease still feared and reviled
in the
global Church... More
World leaders met
in New York last week to discuss the progress of
global efforts to reduce poverty, hunger and
disease.
Nutrition and healthy life styles have always been an interest of mine, but it wasn't until I was diagnosed with Celiac
Disease in March 2010, and became a social work graduate student, that I truly realized the importance of both and my interest
in advancing
global health grew.
World Health Organization
Global Estimates and Regional Comparisons of the Burden of Foodborne
Disease in 2010, PLoS Med 12 (12): e1001923.
In recognition of the fact that coeliac disease affects approximately 1 % of the global population, AOECS fosters strong partnerships with other relevant organisations in and outside of Europ
In recognition of the fact that coeliac
disease affects approximately 1 % of the
global population, AOECS fosters strong partnerships with other relevant organisations
in and outside of Europ
in and outside of Europe.
«The
Global Burden of
Disease Study 2010, from where the quoted study has obtained their data, suggests that
in Australia the biggest causes of mortality or poor health include factors such as obesity, smoking, poor diet and low physical activity.
How Traceability Can Help Prevent Foodborne
Disease: A major impact stirring many
in the packaging industry lately, Tejas Bhatt with the Institute of Food Technologists and the
Global Food Traceability Institute, shared these considerations for traceability: food safety, food sustainability, food security and food defense (i.e. intentional contamination).
Despite a high
global prevalence and inequities
in treatment, kidney
disease is not given priority
in international health plans.
Global, regional, and national prevalence of overweight and obesity
in children and adults during 1980 - 2013: a systematic analysis for the
Global Burden of
Disease Study 2013
Speaking at the time, Sir Leslie Turnberg, Chairman of the UK Public Health Laboratory Service (PHLS) commented: ³ The vital importance of infectious
disease surveillance is clear from the
global increase
in infectious
diseases and the looming threat of antibiotic resistance... The effectiveness of the PHLS is beyond question, and the astonishingly swift identification of the cause of the recent outbreak of salmonellosis from powdered baby milk undoubtedly saved many babies from becoming ill.
She is the co-director of the non profit organization
Global Resource Alliance dedicated to the alleviation of poverty and
disease, and supporting communities
in the Mara region of Tanzania
There is worldwide consensus that there is a
global health crisis
in nutrition 8 and that the costs of diet related
diseases are fast consuming health budgets.
[iii] Changes
in health
in England, with analysis by English regions and areas of deprivation, 1990 — 2013: a systematic analysis for the
Global Burden of
Disease Study 2013 Lancet 2015; 386: 2257 — 74 Published Online September 15, 2015 http://thelancet.com/pdfs/journals/lancet/PIIS0140-6736 (15) 00195 - 6.
Thirty - six of these are
in Africa, which has just three per cent of
global health workers but bears 24 per cent of the
global burden of
disease.
«The World Health Organisation has raised a
global alert because the
disease has affected about 23 countries
in Americas especially
in Latin America.
Global health had long been the domain of physicians, microbiologists, and «a handful of
diseases found
in warm places,» Malkin says.
By contrast, BPD is seldom discussed and it is not included
in the
Global Burden of
Disease study, a comprehensive registry that quantifies
diseases by cost, mortality, geography, risk and other factors.»
After the first human case of SARS was recorded
in 2002
in Guangdong Province
in southern China, a
global epidemic of the
disease sickened more than 8,000 people and killed 774
in 2003.
The plant
disease still causes billions of dollars
in global crop damages annually.
The dramatic rise
in emerging infectious
disease outbreaks of international concern has created an unprecedented challenge for the
global community.
Breeding agricultural crops for resistance against
disease pathogens is essential
in the quest to secure
global food production.
Novartis has set up the Novartis Vaccines Institute for
Global Health based
in Sienna, Italy, which is hunting for vaccines against the most neglected
diseases.
IN A rare instance of humans beating one of the impacts of climate change, measures to combat malaria appear to be neutralising the expected
global increase of the
disease driven by rising temperatures.
But that outlay for dementia research falls well short of those announced
in recent years by the United States and the United Kingdom and even lags Canada's promise at the G8 dementia summit 2 years ago
in London to significantly ramp up its investment
in research on neurodegenerative
diseases as part of a
global bid to find a cure for dementia by 2025.